Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Inventory (2018 - 2025)

Marimed (MRMD) has disclosed Inventory for 8 consecutive years, with $40.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 14.48% to $40.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $40.0 million, a 14.48% increase, with the full-year FY2024 number at $33.5 million, up 32.33% from a year prior.
  • Inventory was $40.0 million for Q3 2025 at Marimed, up from $38.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $40.0 million in Q3 2025 to a low of $7.5 million in Q1 2021.
  • A 5-year average of $23.4 million and a median of $24.2 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: soared 174.5% in 2021, then grew 14.48% in 2025.
  • Marimed's Inventory stood at $9.8 million in 2021, then soared by 99.4% to $19.5 million in 2022, then rose by 29.93% to $25.3 million in 2023, then soared by 32.33% to $33.5 million in 2024, then increased by 19.57% to $40.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Inventory are $40.0 million (Q3 2025), $38.8 million (Q2 2025), and $37.6 million (Q1 2025).